We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Fundación MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals

News   Jun 11, 2012

 
Fundación MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals
 
 
 

RELATED ARTICLES

Grant Fuels Drug Discovery Efforts for ALS

News

Scientists have received a $3.1 million grant to collaborate and investigate drug therapies for amyotrophic lateral sclerosis (ALS).

READ MORE

Drug Targets Early Instigator of Alzheimer's Disease

News

Therapeutic efforts to target "plaques and tangles", considered classic hallmarks of Alzheimer's disease, have previously met with dispiriting failure. Now researchers are exploring a drug called "DYR219" – its strength lies in the fact that it can target both plaques and tangles.

READ MORE

World-first: Genetically Modified Miniature Human Livers Are Grown in the Laboratory

News

Researchers are the first to grow genetically modified miniature human livers in the laboratory, to emulate human liver disease progression and test therapeutics.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE